Chagpar Anees B, Killelea Brigid K, Tsangaris Theodore N, Butler Meghan, Stavris Karen, Li Fangyong, Yao Xiaopan, Bossuyt Veerle, Harigopal Malini, Lannin Donald R, Pusztai Lajos, Horowitz Nina R
From the Departments of Surgery (A.B.C., B.K.K., M.B., K.S., D.R.L., N.R.H.), Pathology (V.B., M.H.), and Medicine (L.P.), Yale Cancer Center (A.B.C., B.K.K., M.B., K.S., F.L., X.Y., D.R.L., L.P., N.R.H.), and Yale Center for Analytical Sciences (F.L., X.Y.), Yale University School of Medicine, New Haven, CT; and the Department of Surgery, Thomas Jefferson University, Philadelphia (T.N.T.).
N Engl J Med. 2015 Aug 6;373(6):503-10. doi: 10.1056/NEJMoa1504473. Epub 2015 May 30.
Routine resection of cavity shave margins (additional tissue circumferentially around the cavity left by partial mastectomy) may reduce the rates of positive margins (margins positive for tumor) and reexcision among patients undergoing partial mastectomy for breast cancer.
In this randomized, controlled trial, we assigned, in a 1:1 ratio, 235 patients with breast cancer of stage 0 to III who were undergoing partial mastectomy, with or without resection of selective margins, to have further cavity shave margins resected (shave group) or not to have further cavity shave margins resected (no-shave group). Randomization occurred intraoperatively after surgeons had completed standard partial mastectomy. Positive margins were defined as tumor touching the edge of the specimen that was removed in the case of invasive cancer and tumor that was within 1 mm of the edge of the specimen removed in the case of ductal carcinoma in situ. The rate of positive margins was the primary outcome measure; secondary outcome measures included cosmesis and the volume of tissue resected.
The median age of the patients was 61 years (range, 33 to 94). On final pathological testing, 54 patients (23%) had invasive cancer, 45 (19%) had ductal carcinoma in situ, and 125 (53%) had both; 11 patients had no further disease. The median size of the tumor in the greatest diameter was 1.1 cm (range, 0 to 6.5) in patients with invasive carcinoma and 1.0 cm (range, 0 to 9.3) in patients with ductal carcinoma in situ. Groups were well matched at baseline with respect to demographic and clinicopathological characteristics. The rate of positive margins after partial mastectomy (before randomization) was similar in the shave group and the no-shave group (36% and 34%, respectively; P=0.69). After randomization, patients in the shave group had a significantly lower rate of positive margins than did those in the no-shave group (19% vs. 34%, P=0.01), as well as a lower rate of second surgery for margin clearance (10% vs. 21%, P=0.02). There was no significant difference in complications between the two groups.
Cavity shaving halved the rates of positive margins and reexcision among patients with partial mastectomy. (Funded by the Yale Cancer Center; ClinicalTrials.gov number, NCT01452399.).
对切缘(保乳手术后在切除腔隙周围额外切除的组织)进行常规切除,可能会降低接受乳腺癌保乳手术患者的切缘阳性(肿瘤切缘阳性)率及再次切除率。
在这项随机对照试验中,我们将235例0至III期乳腺癌且正在接受保乳手术(无论是否切除选择性切缘)的患者按1:1比例随机分组,一组为进一步切除腔隙切缘(切除组),另一组为不进一步切除腔隙切缘(未切除组)。随机分组在外科医生完成标准保乳手术后术中进行。切缘阳性定义为浸润性癌患者切除标本边缘有肿瘤组织,导管原位癌患者切除标本边缘1毫米内有肿瘤组织。切缘阳性率是主要结局指标;次要结局指标包括美容效果和切除组织体积。
患者的中位年龄为61岁(范围33至94岁)。最终病理检查显示,54例(23%)为浸润性癌,45例(19%)为导管原位癌,125例(53%)两者皆有;11例无其他病变。浸润性癌患者肿瘤最大直径的中位值为1.1厘米(范围0至6.5厘米),导管原位癌患者为1.0厘米(范围0至9.3厘米)。两组在人口统计学和临床病理特征方面基线匹配良好。保乳手术后(随机分组前),切除组和未切除组的切缘阳性率相似(分别为36%和34%;P = 0.69)。随机分组后,切除组患者的切缘阳性率显著低于未切除组(19%对34%,P = 0.01),切缘清除的二次手术率也较低(10%对21%,P = 0.02)。两组并发症无显著差异。
对保乳手术患者进行腔隙切除可使切缘阳性率和再次切除率减半。(由耶鲁癌症中心资助;ClinicalTrials.gov编号,NCT01452399。)